Gallant Pet
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $51M
Investors
- 5
About Gallant Pet
, trading under the name Gallant Therapeutics, is a company that provides healthcare solutions using stem cell therapy for dogs and cats. In June 2025, Gallant Pet, Inc. Gallant's offerings includes an off-the-shelf stem cell platform that helps in mitigating symptoms and treating the causes of pet diseases. The firm helps its customers with stem cell collection, stem cell banking, and regenerative treatments for pets.
Who invested in Gallant Pet
5 investors across 3 rounds
See all investors in Gallant Pet
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gallant Pet
Who invested in Gallant Pet?
Gallant Pet has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gallant Pet raised?
Gallant Pet has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gallant Pet last raise money?
Gallant Pet's most recent round on record is a Series B, in Jun 2025.
What does Gallant Pet do?
, trading under the name Gallant Therapeutics, is a company that provides healthcare solutions using stem cell therapy for dogs and cats.
Where is Gallant Pet headquartered?
Gallant Pet is headquartered in San Diego, US.
Which VCs invest in companies like Gallant Pet?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gallant Pet's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Gallant Pet? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.